Dibenzoyl-(+)-p-methoxy-D-tartaric acid

CAS: 191605-10-4

Ref. 3D-FD38002

Product Information

• Name: Dibenzoyl-(+)-p-methoxy-D-tartaric acid
• Synonyms: (2S,3S)-(+)-Di(p-anisoyl)tartaric acid, (2S,3S)-2,3-bis[(4-methoxybenzoyl)oxy]butanedioic acid, (S,S)-Di-p-anisoyltartaric acid, 2,3-Bis[(4-Methoxybenzoyl)Oxy]Butanedioic Acid, Butanedioic acid, 2,3-bis[(4-methoxybenzoyl)oxy]-, (2S,3S)-, Butanedioic acid, 2,3-bis[(4-methoxybenzoyl)oxy]-, [S-(R*,R*)]-, Di(+)-(p-anisoyl)-<span class="text-smallcaps">D</span>-tartrate, Di-P-Anisoyl-D-Tartaric Acid
• CAS: 191605-10-4

Description

Dibenzoyl-(+)-p-methoxy-D-tartaric acid is a macrocyclic molecule that has been synthesized as an enantiomer. It has been found to be an effective drug against schistosomiasis in experimental studies. The compound inhibits the growth of Schistosoma mansoni by preventing the formation of eggs, which are released by the female worms into the environment. Dibenzoyl-(+)-p-methoxy-D-tartaric acid also inhibits the development of larval stages and prevents the release of eggs from male worms. This drug is not yet used clinically for this purpose, but it is being researched for use in tropical regions where schistosomiasis is endemic.

• Brand: Biosynth

Chemical properties

• Molecular weight: 418.35 g/mol
• Formula: C₂₀H₁₈O₁₀
• Purity: Min. 95%
• Color/Form: White Powder
• InChI: InChI=1S/C20H18O10/c1-27-13-7-3-11(4-8-13)19(25)29-15(17(21)22)16(18(23)24)30-20(26)12-5-9-14(28-2)10-6-12/h3-10,15-16H,1-2H3,(H,21,22)(H,23,24)/t15-,16-/m0/s1
• InChI key: InChIKey=KWWCVCFQHGKOMI-HOTGVXAUSA-N
• SMILES: COc1ccc(C(=O)O[C@H](C(=O)O)[C@H](OC(=O)c2ccc(OC)cc2)C(=O)O)cc1